XML 41 R30.htm IDEA: XBRL DOCUMENT v3.25.1
DEBT AND CREDIT FACILITIES (Tables)
3 Months Ended
Mar. 31, 2025
Debt Disclosure [Abstract]  
Schedule of Debt Obligations
A summary of the Company’s debt obligations on its consolidated balance sheets is set forth below:
At March 31, 2025At December 31, 2024
Fair Value
Carrying Value
Fair Value
Carrying Value
5.950% Senior Notes due 2035 (DaVinci) (1)
$293,652 $297,593 $— $— 
5.800% Senior Notes due 2035
497,925 493,704 — — 
5.750% Senior Notes due 2033
748,148 742,300 755,693 742,068 
3.600% Senior Notes due 2029
381,672 396,279 376,816 396,051 
3.450% Senior Notes due 2027
293,037 298,888 290,070 298,765 
3.700% Senior Notes due 2025 (2)
299,904 300,000 299,550 299,908 
4.750% Senior Notes due 2025 (DaVinci) (1)
149,951 149,974 149,363 149,897 
Total senior notes2,664,289 2,678,738 1,871,492 1,886,689 
Medici Revolving Credit Facility (3)
75,000 75,000 — — 
Total debt$2,739,289 $2,753,738 $1,871,492 $1,886,689 
(1)RenaissanceRe owns a noncontrolling economic interest in its joint venture DaVinci. Because RenaissanceRe controls a majority of DaVinci’s issued voting shares, the consolidated financial statements of DaVinci are included in the consolidated financial statements of RenaissanceRe. However, RenaissanceRe does not guarantee or provide credit support for DaVinci and RenaissanceRe’s financial exposure to DaVinci is limited to its investment in DaVinci’s shares and counterparty credit risk arising from reinsurance transactions.
(2)The 3.700% Senior Notes due 2025 were repaid in full at maturity on April 1, 2025. Refer to Note 15. “Subsequent Events” for additional information.
(3)RenaissanceRe owns a noncontrolling economic interest in Medici. Because RenaissanceRe controls all of Medici’s issued voting shares, the financial statements of Medici are included in RenaissanceRe’s consolidated financial statements. However, RenaissanceRe does not guarantee or provide credit support for Medici, and RenaissanceRe’s financial exposure to Medici is limited to its investment in Medici’s shares and counterparty credit risk arising from reinsurance transactions.
Schedule of Outstanding Amounts Issued or Drawn under Credit Facilities
The outstanding amounts issued or drawn under each of the Company’s significant credit facilities are set forth below:
At March 31, 2025
Issued or Drawn
Revolving Credit Facility (1)
$— 
Medici Revolving Credit Facility (2)
75,000 
Bilateral Letter of Credit Facilities
Secured
216,171 
Unsecured
306,316 
$597,487 
(1)At March 31, 2025, no amounts were issued or drawn under this facility.
(2)RenaissanceRe owns a noncontrolling economic interest in Medici. Because RenaissanceRe controls all of Medici’s voting shares, the financial statements of Medici are included in RenaissanceRe’s consolidated financial statements. However, RenaissanceRe does not guarantee or provide credit support for Medici, and RenaissanceRe’s financial exposure to Medici is limited to its investment in Medici’s shares and counterparty credit risk arising from reinsurance transactions. The drawn amount of the Medici revolving credit facility is included on the Company’s consolidated balance sheets under debt.